Workflow
BIO-CHEM(603360)
icon
Search documents
百傲化学(603360) - 2017 Q2 - 季度财报
2017-08-22 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was approximately ¥191 million, representing a 1.99% increase compared to the same period last year[18]. - The net profit attributable to shareholders for the first half of 2017 was approximately ¥54.61 million, a 25.50% increase year-on-year[18]. - The basic earnings per share for the first half of 2017 was ¥0.45, up 2.27% from ¥0.44 in the same period last year[18]. - The net profit after deducting non-recurring gains and losses was approximately ¥51.47 million, reflecting a 24.44% increase compared to the previous year[18]. - The company achieved a main business revenue of 191.02 million RMB, representing a year-on-year growth of 1.99%[30]. - The net profit attributable to shareholders reached 54.61 million RMB, reflecting a significant increase of 25.50% compared to the previous year[30]. - The company reported a significant increase in cash and cash equivalents, reaching RMB 301,736,579.96 as of June 30, 2017, compared to RMB 114,085,492.19 at the beginning of the period, representing a growth of approximately 164%[73]. - The company reported a total comprehensive income of ¥54,592,620.93, up from ¥43,310,077.68 in the previous period[81]. - The total comprehensive income for the period was 60,033,550.00 RMB, reflecting a significant increase compared to the previous period[98]. Assets and Liabilities - The company's total assets increased by 36.74% to approximately ¥856.48 million compared to the end of the previous year[18]. - The company's net assets attributable to shareholders increased by 39.87% to approximately ¥641.86 million compared to the end of the previous year[18]. - Total assets increased to ¥880,759,743.35, up from ¥641,942,887.18, representing a growth of approximately 37.1%[77]. - Current liabilities rose to ¥155,309,244.91 from ¥102,406,464.38, an increase of about 51.7%[77]. - Total liabilities increased to ¥169,689,869.91, compared to ¥119,269,471.23, reflecting a growth of approximately 42.4%[77]. - Total equity reached ¥711,069,873.44, up from ¥522,673,415.95, indicating an increase of around 36.0%[77]. Cash Flow - The net cash flow from operating activities for the first half of 2017 was approximately ¥56.49 million, a 27.73% increase year-on-year[18]. - Cash flow from operating activities increased by 27.73% to 56.49 million RMB, indicating improved sales collection compared to the previous year[33]. - The net cash flow from operating activities generated a net amount of ¥56,492,478.96, an increase of 27.6% from ¥44,229,398.14 in the previous period[86]. - The net cash flow from financing activities was CNY 184,643,636.53, significantly improved from -CNY 23,713,904.83 in the previous period[90]. - The total cash and cash equivalents at the end of the period reached CNY 299,319,209.50, up from CNY 112,524,608.24 at the beginning of the period[90]. Research and Development - Research and development expenses increased by 8.34% to 3.11 million RMB, highlighting the company's commitment to innovation[33]. - The company has obtained 12 invention patents and 8 utility model patents, showcasing its strong R&D and technological innovation capabilities[27]. - The company is focusing on new product development and technological advancements to drive growth in the upcoming periods[98]. Market and Competition - The company specializes in the research, production, and sales of isothiazolinone-based industrial biocides, with a focus on various product series including CIT/MIT, MIT, OIT, DCOIT, and BIT[23]. - The company faces risks from intensified domestic market competition due to increasing environmental requirements and the promotion of isothiazolinone-based biocides, which may attract new competitors and expand existing ones[39]. - The company has established long-term stable partnerships with major chemical giants such as Dow Chemical and Lanxess, ensuring stable foreign sales revenue[31]. Environmental and Safety Risks - The company operates in a heavily polluting industry, with strict adherence to environmental regulations, but potential increases in environmental standards could raise costs and impact profitability[39]. - The company is exposed to safety production risks, including fire hazards during the handling of raw materials, which could lead to significant economic losses if accidents occur[40]. - The company has established strict operational standards to manage environmental impacts from waste generated during production[39]. - The company is committed to increasing environmental investments to comply with legal regulations, which may affect its financial performance[39]. Shareholder and Governance - There are no proposed profit distribution or capital reserve transfer plans for the half-year period[44]. - The company has commitments regarding stock transfer restrictions, including a 36-month lock-up period for major shareholders following the IPO[46]. - Major shareholders are restricted from transferring shares for 12 months post-IPO, with additional conditions if stock prices fall below the issue price[47]. - The company’s strategic investors, including Deep Innovation Investment Management, have established a concerted action relationship, enhancing governance and decision-making[64]. Accounting and Financial Reporting - The accounting policies adhered to the enterprise accounting standards, ensuring transparency and accuracy in financial reporting[106]. - The financial statements are prepared based on the principle of continuous operation, reflecting the company's commitment to long-term growth[104]. - The company recognizes deferred tax assets related to deductible temporary differences if new information indicates that the economic benefits can be realized within 12 months post-acquisition, reducing goodwill accordingly[112]. - The company applies the asset-liability method to recognize deferred tax assets and liabilities based on temporary differences between the book value and tax base of assets and liabilities[167]. Accounts Receivable and Provisions - The total accounts receivable at the end of the period amounted to ¥85,389,406.23, with a total bad debt provision of ¥5,579,833.53, representing a provision rate of approximately 6.53%[185]. - The company recognized a bad debt provision of ¥295,395.87 during the period, while recovering or reversing bad debt provisions amounted to ¥1,670.47[186]. - The actual write-off of accounts receivable during the period was ¥63,600.60, primarily due to long aging and inability to recover[189].
百傲化学(603360) - 2017 Q1 - 季度财报
2017-04-27 16:00
2017 年第一季度报告 公司代码:603360 公司简称:百傲化学 大连百傲化学股份有限公司 2017 年第一季度报告 1 / 18 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 5 | | 四、 | 附录 | 8 | 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人刘宪武、主管会计工作负责人高兵及会计机构负责人(会计主管人员)刘东光保 证季度报告中财务报表的真实、准确、完整。 1.4 本公司第一季度报告未经审计。 二、 公司基本情况 2017 年第一季度报告 2.1 主要财务数据 单位:元 币种:人民币 | | 本报告期末 | 上年度末 | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | | | | | 减(%) | | | 总资产 | 833,934,961.07 | 626,367,8 ...
百傲化学(603360) - 2016 Q4 - 年度财报
2017-04-23 16:00
Financial Performance - The company achieved a consolidated net profit of ¥97,945,999.65 for the year 2016, representing a significant increase of 71.39% compared to the previous year[3]. - Total operating revenue for 2016 was ¥389,433,985.09, reflecting an 18.73% increase from ¥327,991,416.10 in 2015[21]. - The net cash flow from operating activities reached ¥119,767,902.83, which is a 61.77% increase compared to ¥74,035,564.97 in 2015[21]. - The company's total assets as of December 31, 2016, amounted to ¥626,367,873.82, a 14.25% increase from ¥548,252,387.80 at the end of 2015[21]. - The net assets attributable to shareholders of the listed company increased by 27.26% to ¥458,889,228.75 at the end of 2016, up from ¥360,595,037.05 in 2015[21]. - Basic earnings per share increased by 71.93% to CNY 0.98 in 2016 compared to CNY 0.57 in 2015[22]. - The weighted average return on equity rose to 23.98%, an increase of 6.70 percentage points from 17.28% in 2015[22]. - The company reported a net profit attributable to shareholders after deducting non-recurring gains and losses of ¥93,064,938.11, which is a 73.16% increase from the previous year[21]. Dividends and Shareholder Returns - The company plans to distribute a total of ¥133,340,000 in cash dividends to shareholders, amounting to ¥10 per 10 shares (including tax)[3]. - In 2016, the company distributed cash dividends amounting to approximately 133.34 million RMB, representing 135.68% of the net profit attributable to ordinary shareholders[95]. - The company has established a cash dividend policy, committing to distribute at least 20% of the annual distributable profit as cash dividends, provided the net profit is positive[93]. Operational Highlights - The company’s main business focuses on the research, production, and sales of isothiazolinone-based industrial biocides, which are widely used across various industries[31]. - The production model is based on a "sales-driven production" approach, allowing for flexible manufacturing to meet customer-specific requirements[32]. - The company has established long-term stable partnerships with over 500 domestic clients and nearly 100 international clients, including major multinational corporations[36]. - The company has become the largest producer of isothiazolinone biocides in Asia, indicating a strong market position[65]. - The production capacity for isothiazolinone products exceeded 10,000 tons, establishing the company as a leading player in this niche market[35]. Research and Development - Research and development expenses increased by 33.80% to ¥13,791,914.15, highlighting the company's commitment to innovation[43]. - The company has developed 11 invention patents, showcasing its strong technological innovation capabilities[35]. - The company plans to increase R&D investment, aiming to enhance the proportion of R&D expenses in sales revenue over the next three years[85]. - The company will continue to improve its internal talent development and recruitment mechanisms to enhance its R&D capabilities and management strength[86]. Market and Sales Performance - The sales volume of CIT/MIT products increased by 18.60% compared to the previous year, reaching 16,545.58 tons[48]. - The gross profit margin for the South China region was 56.24%, with a revenue increase of 27.01% year-over-year[46]. - The company reported a significant increase in sales from the North America region, with a revenue of approximately 25.64 million, up by 29.03%[46]. - The company’s OIT product sales grew significantly, driven by increased demand from both new and existing customers[47]. Financial Position and Cash Flow - The company's cash and cash equivalents rose to ¥114,085,492.19, representing 18.21% of total assets, a 326% increase from the previous period[58]. - The total cash and cash equivalents at the end of the period increased to CNY 113,983,167.53 from CNY 26,655,372.89, marking a substantial increase of approximately 327.5%[170]. - The net cash flow from investment activities improved by 72.03%, reducing the outflow to ¥2,898,673.93[57]. - The financial expenses decreased significantly by 78.32%, totaling 1.77 million compared to the previous year[53]. Governance and Compliance - The board of directors confirmed the accuracy and completeness of the annual report, ensuring no false records or misleading statements[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[5]. - The company has not violated any decision-making procedures for providing guarantees[5]. - The company has not encountered any non-standard audit opinions during the reporting period[101]. - The company has not reported any significant litigation or arbitration matters during the fiscal year[104]. Shareholder Structure and Management - The total number of ordinary shareholders at the end of the reporting period was 7, compared to 17,261 at the end of the previous month[113]. - The company completed its initial public offering of 33.34 million shares, increasing the total share capital from 100 million to 133.34 million shares[111]. - The top ten shareholders include Tongyun Investment and Sanxin Investment, each holding 38,666,667 shares, representing 38.67% of the total shares[115]. - The company has maintained a stable management team with no changes in shareholding among the directors and supervisors[125]. Risks and Challenges - The company recognizes risks such as intensified domestic market competition and potential core technology leakage, which could adversely affect production and sustainable development[89]. - The company is committed to adhering to environmental regulations and has implemented strict operational standards to mitigate environmental risks associated with its production processes[89]. Accounting and Financial Reporting - The company has maintained a stable accounting policy, ensuring compliance with relevant accounting standards[194]. - The company’s financial statements reflect a strong commitment to continuous operation without significant doubts regarding its operational capability[192]. - The company’s accounting currency is Renminbi, ensuring consistency in financial reporting[197].